Exact Sciences Buys Cancer Detection Cos. For Up To $2.56B
Cancer treatment developer Exact Sciences on Tuesday announced the separate acquisitions of two cancer detection companies totaling as much as $2.56 billion, including one agreement worth up to $2.15 billion, in...To view the full article, register now.
Already a subscriber? Click here to view full article